Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Geriatr Oncol. 2020 Mar 10;11(6):960–968. doi: 10.1016/j.jgo.2020.02.006

Figure 3:

Figure 3:

Receipt of emotional distress medication for self-report functional limitation among SEER-MHOS respondents with cancer. All P-values are <0.01 across functional limitation categories for receipt of any emotional distress medication and each type of emotional distress medication. Note: Participants could be taking more than one medication class.